AFAnna C. Felmer

Anna C. Felmer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna C. Felmer has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Alexyss Guy

    Department of Pharmacy, Cleveland Clinic Children’s Hospital, Cleveland, USA

    1 shared publication
  • Amrita Nayak

    Department of Pediatrics, Division of Neonatology, NYU Langone Hospital - Long Island, NYU Grossman Long Island School of Medicine, Mineola, USA

    1 shared publication
  • Austin Han

    Department of Pediatrics, Division of Neonatal-Perinatal Medicine, Cohen Children’s Medical Center, Northwell Health, New Hyde Park, USA

    1 shared publication
  • Christina Gerber

    Department of Pharmacy, Rainbow Babies and Children’s Hospital, Cleveland, USA

    1 shared publication
  • Dave Gothard

    Biostats Inc, East Canton, USA

    1 shared publication
  • Diana Kwiatkowski

    Department of Pharmacy, Mount Sinai Hospital, New York, USA

    1 shared publication

Latest Publications

  • Open Access

    Comparison of growth and morbidity outcomes in preterm infants using two different intravenous lipid emulsions

    by Alexyss Guy, Austin Han, Diana Kwiatkowski, Anna C. Felmer, Christina Gerber, Rachel H. Lee, Amrita Nayak, Rebecca Goodman, Dave Gothard, Rita M. Ryan, et al.

    Objectives: To compare growth z-scores and prematurity-related comorbidities for preterm infants receiving Soybean Oil-Intravenous Lipid Emulsion (SO-ILE) versus Soybean + Medium-chain triglycerides + Olive + Fish oil ILE (SMOF-ILE). Study design: A multicenter, retrospective cohort study of 347 preterm infants n = 179) demonstrated significantly improved growth for length ( p ≤ 0.001) and head circumference z-scores ( p = 0.015) at 36 weeks’ postmenstrual age and significantly worse growth for weight z-scores at 1 month ( p = 0.017) compared to the SMOF-ILE group ( n = 168). SO-ILE group had significantly lower rates of bronchopulmonary dysplasia (BPD) ( p < 0.001) and urinary tract infections (UTI) ( p = 0.045). Conclusion: In this population, SO-ILE had better outcomes for growth, BPD, and UTI compared to SMOF-ILE. Therefore, SO-ILE remains a reasonable lipid emulsion for preterm infants until more evidence is available.